إعلان
إعلان

PALI

PALI logo

Palisade Bio, Inc. Common Stock

1.91
USD
برعاية
-0.11
-5.69%
٠٨ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

1.92

+0.01
+0.52%

تقارير أرباح PALI

النسبة الإيجابية المفاجئة

PALI تفوق 15 من 24 آخر التقديرات.

63%

التقرير التالي

بيانات التقرير القادم
٢٣ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.14
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/
-63.16%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/
-90.91%

Palisade Bio, Inc. Common Stock earnings per share and revenue

On ١٠ نوفمبر ٢٠٢٥, PALI reported earnings of -0.38 USD per share (EPS) for Q3 25, missing the estimate of -0.27 USD, resulting in a -35.81% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +2.82% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 المحللين forecast an EPS of -0.14 USD, with revenue projected to reach -- USD, implying an نقصان of -63.16% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Palisade Bio, Inc. Common Stock reported EPS of -$0.38, missing estimates by -35.81%, and revenue of $0.00, 0% as expectations.
The stock price moved up 2.82%, changed from $1.77 before the earnings release to $1.82 the day after.
The next earning report is scheduled for ٢٣ مارس ٢٠٢٦.
Based on 5 المحللين, Palisade Bio, Inc. Common Stock is expected to report EPS of -$0.14 and revenue of -- for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان